Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information... Show more
FLGT is expected to report earnings to fall 302.25% to -8 cents per share on May 02
Q1'25
Est.
$-0.08
Q4'24
Beat
by $0.43
Q3'24
Beat
by $0.46
Q2'24
Beat
by $0.45
Q1'24
Beat
by $0.31
The last earnings report on February 28 showed earnings per share of 3 cents, beating the estimate of -38 cents. With 394.24K shares outstanding, the current market capitalization sits at 648.84M.